Product Code: 4811
The lacrimal devices market is expected to witness exponential growth by 2028 on account of recent technological advancements in the product. In addition, rising prevalence of eye diseases across the globe is likely to bolster market expansion over the forecast period.
Recent technological advancements have considerably enhanced lacrimal treatment procedures worldwide. Additionally, the rollout of numerous innovative lacrimal devices has augmented industry adoption over the past few years.
Moreover, industry players have been implementing strategic initiatives to gain a competitive edge in the evolving marketplace, thereby strengthening the overall business scenario. For instance, in June 2020, Kaneka Corporation, a Japan-based chemical manufacturing company, inked a partnership agreement with Rohto Pharmaceutical Co., Ltd., a global consumer goods and pharmaceutical company. According to the deal, both firms agreed to combine their product development, branding, and sales expertise to strengthen the lacrimal duct tube business.
In another instance, in December 2020, FCI Ophthalmics Inc, a prominent manufacturer of ophthalmic surgical devices, launched its novel nasolacrimal intubation preloaded on an injector, dubbed the LacriJet. The LacriJet has been designed to minimize patient discomfort, significantly reduce operating time, and provide efficient results.
The lacrimal devices market has been segmented on the basis of end-use, product, application, and region. In terms of product, the market has further been bifurcated into punctal plugs, intubation sets, dilator, tubes, cannula & spatula, stents, and others. The tubes sub-segment held a market share of about 11.4% in 2021 and is set to expand at a robust pace over the review timeline.
From the application point of view, the market has been categorized into lacrimal gland inflammation, dry eye, drainage obstruction, epiphora, glaucoma, and others. The lacrimal devices market size from the epiphora sub-segment is slated to progress at a significant CAGR to reach a valuation of around USD 19.4 million by the end of 2028.
With respect to end-use, the lacrimal devices market has been segregated into diagnostic centers, hospitals, ophthalmic clinics, and others. In 2021, the diagnostic centers sub-segment was valued at over USD 14.6 million and is projected to garner sizable gains by the end of the assessment period.
On the regional spectrum, the Latin America lacrimal devices industry accounted for almost 11.0% market share in 2021 and is poised to gain substantial traction through the analysis timeframe. Meanwhile, the Middle East & Africa lacrimal devices market is speculated to develop at a CAGR of approximately 3.9% over the forecast timeline to reach a considerable valuation by the end of 2028.
Table of Contents
Chapter 1 Methodology
- 1.1 Market definitions
- 1.2 Base estimates & working
- 1.2.1 North America
- 1.2.2 Europe
- 1.2.3 Asia Pacific
- 1.2.4 Latin America
- 1.2.5 Middle East & Africa
- 1.3 Forecast parameters
- 1.4 Data validation
- 1.5 Data Sources
- 1.5.1 Secondary
- 1.5.1.1 Paid sources
- 1.5.1.2 Unpaid sources
- 1.5.2 Primary
Chapter 2 Executive Summary
- 2.1 Lacrimal devices industry 360 degree synopsis, 2017 - 2028
- 2.1.1 Business trends
- 2.1.2 Product trends
- 2.1.3 Application trends
- 2.1.4 End-use trends
- 2.1.5 Regional trends
Chapter 3 Lacrimal Devices Industry Insights
- 3.1 Industry segmentation
- 3.2 Industry landscape, 2017 - 2028
- 3.3 Industry impact forces
- 3.3.1 Growth drivers
- 3.3.1.1 Growing prevalence of eye disease
- 3.3.1.2 Ease of lacrimal treatment procedures
- 3.3.1.3 Technological advancements in lacrimal devices
- 3.3.2 Industry pitfalls & challenges
- 3.3.2.1 High risk of side effects
- 3.4 Growth potential analysis
- 3.4.1 By product
- 3.4.2 By application
- 3.4.3 By end-use
- 3.5 COVID-19 impact analysis
- 3.6 Porter's analysis
- 3.7 Competitive landscape
- 3.7.1 Company matrix analysis, 2021
- 3.8 PESTEL analysis
Chapter 4 Lacrimal Devices Market, By Product
- 4.1 Key segment trends
- 4.2 Intubation sets
- 4.2.1 Market size, by region, 2017 - 2028 (USD Million)
- 4.3 Tubes
- 4.3.1 Market size, by region, 2017 - 2028 (USD Million)
- 4.4 Stents
- 4.4.1 Market size, by region, 2017 - 2028 (USD Million)
- 4.5 Cannula & Spatula
- 4.5.1 Market size, by region, 2017 - 2028 (USD Million)
- 4.6 Dilator
- 4.6.1 Market size, by region, 2017 - 2028 (USD Million)
- 4.7 Punctal plugs
- 4.7.1 Market size, by region, 2017 - 2028 (USD Million)
- 4.8 Others
- 4.8.1 Market size, by region, 2017 - 2028 (USD Million)
Chapter 5 Lacrimal Devices Market, By Application
- 5.1 Key segment trends
- 5.2 Dry eye
- 5.2.1 Market size, by region, 2017 - 2028 (USD Million)
- 5.3 Epiphora
- 5.3.1 Market size, by region, 2017 - 2028 (USD Million)
- 5.4 Glaucoma
- 5.4.1 Market size, by region, 2017 - 2028 (USD Million)
- 5.5 Drainage obstruction
- 5.5.1 Market size, by region, 2017 - 2028 (USD Million)
- 5.6 Lacrimal gland inflammation
- 5.6.1 Market size, by region, 2017 - 2028 (USD Million)
- 5.7 Others
- 5.7.1 Market size, by region, 2017 - 2028 (USD Million)
Chapter 6 Lacrimal Devices Market, By End-use
- 6.1 Key segment trends
- 6.2 Hospitals
- 6.2.1 Market size, by region, 2017 - 2028 (USD Million)
- 6.3 Ophthalmic clinics
- 6.3.1 Market size, by region, 2017 - 2028 (USD Million)
- 6.4 Diagnostic centers
- 6.4.1 Market size, by region, 2017 - 2028 (USD Million)
- 6.5 Others
- 6.5.1 Market size, by region, 2017 - 2028 (USD Million)
Chapter 7 Lacrimal Market, By Region
- 7.1 Key regional trends
- 7.2 North America
- 7.2.1 Market size, by country, 2017 - 2028 (USD Million)
- 7.2.2 Market size, by product, 2017 - 2028 (USD Million)
- 7.2.3 Market size, by application, 2017 - 2028 (USD Million)
- 7.2.4 Market size, by end-use, 2017 - 2028 (USD Million)
- 7.2.5 U.S.
- 7.2.5.1 Market size, by product, 2017 - 2028 (USD Million)
- 7.2.5.2 Market size, by application, 2017 - 2028 (USD Million)
- 7.2.5.3 Market size, by end-use, 2017 - 2028 (USD Million)
- 7.2.6 Canada
- 7.2.6.1 Market size, by product, 2017 - 2028 (USD Million)
- 7.2.6.2 Market size, by application, 2017 - 2028 (USD Million)
- 7.2.6.3 Market size, by end-use, 2017 - 2028 (USD Million)
- 7.3 Europe
- 7.3.1 Market size, by country, 2017 - 2028 (USD Million)
- 7.3.2 Market size, by product, 2017 - 2028 (USD Million)
- 7.3.3 Market size, by application, 2017 - 2028 (USD Million)
- 7.3.4 Market size, by end-use, 2017 - 2028 (USD Million)
- 7.3.5 Germany
- 7.3.5.1 Market size, by product, 2017 - 2028 (USD Million)
- 7.3.5.2 Market size, by application, 2017 - 2028 (USD Million)
- 7.3.5.3 Market size, by end-use, 2017 - 2028 (USD Million)
- 7.3.6 UK
- 7.3.6.1 Market size, by product, 2017 - 2028 (USD Million)
- 7.3.6.2 Market size, by application, 2017 - 2028 (USD Million)
- 7.3.6.3 Market size, by end-use, 2017 - 2028 (USD Million)
- 7.3.7 France
- 7.3.7.1 Market size, by product, 2017 - 2028 (USD Million)
- 7.3.7.2 Market size, by application, 2017 - 2028 (USD Million)
- 7.3.7.3 Market size, by end-use, 2017 - 2028 (USD Million)
- 7.3.8 Italy
- 7.3.8.1 Market size, by product, 2017 - 2028 (USD Million)
- 7.3.8.2 Market size, by application, 2017 - 2028 (USD Million)
- 7.3.8.3 Market size, by end-use, 2017 - 2028 (USD Million)
- 7.3.9 Spain
- 7.3.9.1 Market size, by product, 2017 - 2028 (USD Million)
- 7.3.9.2 Market size, by application, 2017 - 2028 (USD Million)
- 7.3.9.3 Market size, by end-use, 2017 - 2028 (USD Million)
- 7.3.10 Russia
- 7.3.10.1 Market size, by product, 2017 - 2028 (USD Million)
- 7.3.10.2 Market size, by application, 2017 - 2028 (USD Million)
- 7.3.10.3 Market size, by end-use, 2017 - 2028 (USD Million)
- 7.4 Asia Pacific
- 7.4.1 Market size, by country, 2017 - 2028 (USD Million)
- 7.4.2 Market size, by product, 2017 - 2028 (USD Million)
- 7.4.3 Market size, by application, 2017 - 2028 (USD Million)
- 7.4.4 Market size, by end-use, 2017 - 2028 (USD Million)
- 7.4.5 Japan
- 7.4.5.1 Market size, by product, 2017 - 2028 (USD Million)
- 7.4.5.2 Market size, by application, 2017 - 2028 (USD Million)
- 7.4.5.3 Market size, by end-use, 2017 - 2028 (USD Million)
- 7.4.6 China
- 7.4.6.1 Market size, by product, 2017 - 2028 (USD Million)
- 7.4.6.2 Market size, by application, 2017 - 2028 (USD Million)
- 7.4.6.3 Market size, by end-use, 2017 - 2028 (USD Million)
- 7.4.7 India
- 7.4.7.1 Market size, by product, 2017 - 2028 (USD Million)
- 7.4.7.2 Market size, by application, 2017 - 2028 (USD Million)
- 7.4.7.3 Market size, by end-use, 2017 - 2028 (USD Million)
- 7.4.8 Australia
- 7.4.8.1 Market size, by product, 2017 - 2028 (USD Million)
- 7.4.8.2 Market size, by application, 2017 - 2028 (USD Million)
- 7.4.8.3 Market size, by end-use, 2017 - 2028 (USD Million)
- 7.4.9 South Korea
- 7.4.9.1 Market size, by product, 2017 - 2028 (USD Million)
- 7.4.9.2 Market size, by application, 2017 - 2028 (USD Million)
- 7.4.9.3 Market size, by end-use, 2017 - 2028 (USD Million)
- 7.5 Latin America
- 7.5.1 Market size, by country, 2017 - 2028 (USD Million)
- 7.5.2 Market size, by product, 2017 - 2028 (USD Million)
- 7.5.3 Market size, by application, 2017 - 2028 (USD Million)
- 7.5.4 Market size, by end-use, 2017 - 2028 (USD Million)
- 7.5.5 Brazil
- 7.5.5.1 Market size, by product, 2017 - 2028 (USD Million)
- 7.5.5.2 Market size, by application, 2017 - 2028 (USD Million)
- 7.5.5.3 Market size, by end-use, 2017 - 2028 (USD Million)
- 7.5.6 Mexico
- 7.5.6.1 Market size, by product, 2017 - 2028 (USD Million)
- 7.5.6.2 Market size, by application, 2017 - 2028 (USD Million)
- 7.5.6.3 Market size, by end-use, 2017 - 2028 (USD Million)
- 7.5.7 Argentina
- 7.5.7.1 Market size, by product, 2017 - 2028 (USD Million)
- 7.5.7.2 Market size, by application, 2017 - 2028 (USD Million)
- 7.5.7.3 Market size, by end-use, 2017 - 2028 (USD Million)
- 7.6 MEA
- 7.6.1 Market size, by country, 2017 - 2028 (USD Million)
- 7.6.2 Market size, by product, 2017 - 2028 (USD Million)
- 7.6.3 Market size, by application, 2017 - 2028 (USD Million)
- 7.6.4 Market size, by end-use, 2017 - 2028 (USD Million)
- 7.6.5 South Africa
- 7.6.5.1 Market size, by product, 2017 - 2028 (USD Million)
- 7.6.5.2 Market size, by application, 2017 - 2028 (USD Million)
- 7.6.5.3 Market size, by end-use, 2017 - 2028 (USD Million)
- 7.6.6 Saudi Arabia
- 7.6.6.1 Market size, by product, 2017 - 2028 (USD Million)
- 7.6.6.2 Market size, by application, 2017 - 2028 (USD Million)
- 7.6.6.3 Market size, by end-use, 2017 - 2028 (USD Million)
- 7.6.7 UAE
- 7.6.7.1 Market size, by product, 2017 - 2028 (USD Million)
- 7.6.7.2 Market size, by application, 2017 - 2028 (USD Million)
- 7.6.7.3 Market size, by end-use, 2017 - 2028 (USD Million)
Chapter 8 Company Profiles
- 8.1 Competitive dashboard, 2021
- 8.2 FCI Ophthalmic
- 8.2.1 Business overview
- 8.2.2 Financial data
- 8.2.3 Product landscape
- 8.2.4 Strategic outlook
- 8.2.5 SWOT analysis
- 8.3 Medennium
- 8.3.1 Business overview
- 8.3.2 Financial data
- 8.3.3 Product landscape
- 8.3.4 Strategic outlook
- 8.3.5 SWOT analysis
- 8.4 BVI
- 8.4.1 Business overview
- 8.4.2 Financial data
- 8.4.3 Product landscape
- 8.4.4 Strategic outlook
- 8.4.5 SWOT analysis
- 8.5 Lacrimedics Inc
- 8.5.1 Business overview
- 8.5.2 Financial data
- 8.5.3 Product landscape
- 8.5.4 Strategic outlook
- 8.5.5 SWOT analysis
- 8.6 Rumex International Co
- 8.6.1 Business overview
- 8.6.2 Financial data
- 8.6.3 Product landscape
- 8.6.4 Strategic outlook
- 8.6.5 SWOT analysis
- 8.7 Bess Medical Technology GmbH
- 8.7.1 Business overview
- 8.7.2 Financial data
- 8.7.3 Product landscape
- 8.7.4 Strategic outlook
- 8.7.5 SWOT analysis
- 8.8 Kaneka Corporation
- 8.8.1 Business overview
- 8.8.2 Financial data
- 8.8.3 Product landscape
- 8.8.4 Strategic outlook
- 8.8.5 SWOT analysis
- 8.9 Braintree Scientific
- 8.9.1 Business overview
- 8.9.2 Financial data
- 8.9.3 Product landscape
- 8.9.4 Strategic outlook
- 8.9.5 SWOT analysis
- 8.10 JEDMED
- 8.10.1 Business overview
- 8.10.2 Financial data
- 8.10.3 Product landscape
- 8.10.4 Strategic outlook
- 8.10.5 SWOT analysis
- 8.11 Walsh Medical Devices Inc
- 8.11.1 Business overview
- 8.11.2 Financial data
- 8.11.3 Product landscape
- 8.11.4 Strategic outlook
- 8.11.5 SWOT analysis